Industry
SpectralMD
Total Trials
6
Recruiting
0
Active
0
Completed
5
Success Rate
83.3%-3% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
Failure Rate
16.7%
1 terminated/withdrawn out of 6 trials
Success Rate
83.3%
-3.2% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
No phase data available
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (6)
Showing 6 of 6 trials
NCT06131203Completed
Burn Validation Study
Role: lead
NCT05581966Completed
Wound Assessment Using Spectral Imaging EU/UK
Role: lead
NCT05415683Completed
Wound Assessment Using Spectral Imaging US
Role: lead
NCT03611361Terminated
Wound Imaging Study to Gather Clinical References for a Device to Assist Selecting Level-of-amputation in PAD Patients
Role: lead
NCT06024512Completed
DeepView Snapshot Handheld (DV-H) Comparison Study
Role: lead
NCT05023135Completed
DeepView SnapShot Portable (DV-SSP): Device Training Study
Role: lead
All 6 trials loaded